8篇
您的检索式：作者名="Whitfield DM"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Multiple-dose pharmacokinetics,pharmacodynamics and safety of atorvastatin,an inhibitor of HMG-CoA reductase,in healthy subjects显示文摘 | Whitfield LR Gibson DM | 1996 | Clin Pharmacol Ther1996，60，6： | 1 |
| 2 | Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening显示文摘 | Gibson DM Whitfield LR | 1996 | Clin Pharmacol1996，36，7： | 1 |
| 3 | Multiple-dose pharmacokinetics,pharmacodynamics,and safety of torvastatin,an inhibitor of HMG-CoA reductase,in healthy subjects显示文摘 | Cilla DD Jr Whitfield LR Gibson DM | 1996 | Clin Pharmacol Ther1996，60，6： | 1 |
| 4 | Development of specific inhibitors for heparin-binding proteins based on the cobra cardiotoxin structure: an effective synthetic strategy for rationally modified heparin-likedisaccharides and a trisaccharide 显示文摘 | Ke W Whitfield DM Brission JR | 2005 | Carbohydr Res2005，340，3： | 1 |
| 5 | Mutiple-dose pharmacokinetics, pharmacodinamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects 显示文摘 | Cilla DD Whitfield LR Gibson DM | 1996 | J Clin Pharmacol1996，60，6： | 1 |
| 6 | Multiple-dose pharmacokinetics,pharmacodynamics,and safety of atorvastatin,an inhibitor of HMG-CoA reductase,in healthy subjects显示文摘 | Cilla DD Whitfield LR Gibson DM | 1996 | Clin Pharmacol Ther1996，60，： | 1 |
| 7 | Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening显示文摘 | Cilla DD Jr Gibson DM Whitfield LR Sedman AJ | 1996 | J Clin Pharmacol1996，36，： | 1 |
| 8 | Pharmacodyna-mic effects and pharmacokinetics of atorvastatin after adminis-tration to normocholesterolemic subjects in the morning andevening 显示文摘 | Cilla Jr DD Gibson DM Whitfield LR | 1996 | Clin Pharmacol1996，36，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员